Clinical Trial

Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the efficacy of topical products in providing protection against the visible light and ultraviolet A1 (UVA1) part of sunlight. Ultraviolet radiation and visible light are both components of sunlight that reach the earth. It is important to test these topical products against visible light and UVA1 because our current sunscreens may not protect against these very well.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-11-26; most recent amendment 2026-05-19.
Status change: Active, Not Recruiting → Completed 2023-06-21
Status change: Recruiting → Active, Not Recruiting 2022-01-27
Trial Details
NCT Number NCT04181476
Lead Sponsor Henry Ford Health System
Collaborators: L'Oreal
Conditions Sun Damaged Skin
Enrollment 12 participants
Start Date 2019-11-05
Primary Completion 2021-01-18 (estimated)
Study Completion 2022-06 (estimated)
Updated on ClinicalTrials.gov 2022-01-28